Compare
Abbott Laboratories vs LeMaitre Vascular (ABT vs LMAT)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Abbott Laboratories (ABT) returned -11.7% and LeMaitre Vascular (LMAT) -6.2%; so far this year the figures are -12.3% and -0.3%.
Abbott Laboratories is the larger company by market value, about 102.9 times the size of LeMaitre Vascular.
On trailing earnings, ABT trades at 40.9 times and LMAT at 29.4 times.
Revenue grew +10.0% at ABT and +11.8% at LMAT over the last year.
ABT yields 2.29%. LMAT yields 1.17%.
Data as of the latest close. Not investment advice.
Relative performance
| ABT | LMAT | |
|---|---|---|
| Price | $109.93 | $80.89 |
| 1-day | -3.23% | -3.11% |
| YTD | -12.26% | -0.26% |
| 1 year | -11.73% | -6.24% |
| 3 years | +15.70% | +69.16% |
| Market cap | $190.4B | $1.9B |
| P/E | 40.9 | 29.4 |
| P/S | 3.95 | 6.87 |
| P/B | 3.73 | 4.28 |
| Revenue growth | +10.00% | +11.80% |
| EPS growth | -66.20% | +19.00% |
| Gross margin % | 56.9 | 72.0 |
| Net margin % | 9.7 | 23.5 |
| ROE % | 9.2 | 14.7 |
| Debt / equity | 0.61 | 0.00 |
| FCF yield % | 3.5 | 3.6 |
| Dividend yield % | 2.29 | 1.17 |
| Beta | 0.06 | 0.62 |
| RSI (14) | 58.5 | 46.5 |
| Technical rating |